OBJECTIVE: The cause of stroke remains unknown or cryptogenic in many patients. We sought to determine whether gene expression signatures in blood can distinguish between cardioembolic and large-vessel causes of stroke, and whether these profiles can predict stroke etiology in the cryptogenic group. METHODS: A total of 194 samples from 76 acute ischemic stroke patients were analyzed. RNA was isolated from blood and run on Affymetrix U133 Plus2.0 microarrays. Genes that distinguish large-vessel from cardioembolic stroke were determined at 3, 5, and 24 hours following stroke onset. Predictors were evaluated using cross-validation and a separate set of patients with known stroke subtype. The cause of cryptogenic stroke was predicted based on a model developed from strokes of known cause and identified predictors. RESULTS: A 40-gene profile differentiated cardioembolic stroke from large-vessel stroke with >95% sensitivity and specificity. A separate 37-gene profile differentiated cardioembolic stroke due to atrial fibrillation from nonatrial fibrillation causes with >90% sensitivity and specificity. The identified genes elucidate differences in inflammation between stroke subtypes. When applied to patients with cryptogenic stroke, 17% are predicted to be large-vessel and 41% to be cardioembolic stroke. Of the cryptogenic strokes predicted to be cardioembolic, 27% were predicted to have atrial fibrillation. INTERPRETATION: Gene expression signatures distinguish cardioembolic from large-vessel causes of ischemic stroke. These gene profiles may add valuable diagnostic information in the management of patients with stroke of unknown etiology though they need to be validated in future independent, large studies.
OBJECTIVE: The cause of stroke remains unknown or cryptogenic in many patients. We sought to determine whether gene expression signatures in blood can distinguish between cardioembolic and large-vessel causes of stroke, and whether these profiles can predict stroke etiology in the cryptogenic group. METHODS: A total of 194 samples from 76 acute ischemic strokepatients were analyzed. RNA was isolated from blood and run on Affymetrix U133 Plus2.0 microarrays. Genes that distinguish large-vessel from cardioembolic stroke were determined at 3, 5, and 24 hours following stroke onset. Predictors were evaluated using cross-validation and a separate set of patients with known stroke subtype. The cause of cryptogenic stroke was predicted based on a model developed from strokes of known cause and identified predictors. RESULTS: A 40-gene profile differentiated cardioembolic stroke from large-vessel stroke with >95% sensitivity and specificity. A separate 37-gene profile differentiated cardioembolic stroke due to atrial fibrillation from nonatrial fibrillation causes with >90% sensitivity and specificity. The identified genes elucidate differences in inflammation between stroke subtypes. When applied to patients with cryptogenic stroke, 17% are predicted to be large-vessel and 41% to be cardioembolic stroke. Of the cryptogenic strokes predicted to be cardioembolic, 27% were predicted to have atrial fibrillation. INTERPRETATION: Gene expression signatures distinguish cardioembolic from large-vessel causes of ischemic stroke. These gene profiles may add valuable diagnostic information in the management of patients with stroke of unknown etiology though they need to be validated in future independent, large studies.
Authors: Xinli Du; Yang Tang; Huichun Xu; Lisa Lit; Wynn Walker; Paul Ashwood; Jeffrey P Gregg; Frank R Sharp Journal: Genomics Date: 2006-03-20 Impact factor: 5.736
Authors: Ralph L Sacco; Shyam Prabhakaran; J L P Thompson; Amy Murphy; Robert R Sciacca; Bruce Levin; J-P Mohr Journal: Cerebrovasc Dis Date: 2006-03-27 Impact factor: 2.762
Authors: L B Goldstein; M R Jones; D B Matchar; L J Edwards; J Hoff; V Chilukuri; S B Armstrong; R D Horner Journal: Stroke Date: 2001-05 Impact factor: 7.914
Authors: Ahamad Hassan; Beverley J Hunt; Michael O'Sullivan; Kiran Parmar; John M Bamford; Dennis Briley; Martin M Brown; Dafydd J Thomas; Hugh S Markus Journal: Brain Date: 2003-02 Impact factor: 13.501
Authors: A H Tayal; M Tian; K M Kelly; S C Jones; D G Wright; D Singh; J Jarouse; J Brillman; S Murali; R Gupta Journal: Neurology Date: 2008-09-24 Impact factor: 9.910
Authors: Tjun Y Tang; Karin H Muller; Martin J Graves; Zhi Y Li; Stewart R Walsh; Victoria Young; Umar Sadat; Simon P S Howarth; J H Gillard Journal: Arterioscler Thromb Vasc Biol Date: 2009-02-19 Impact factor: 8.311
Authors: Arthur M Pancioli; Joseph Broderick; Thomas Brott; Thomas Tomsick; Jane Khoury; Judy Bean; Gregory del Zoppo; Dawn Kleindorfer; Daniel Woo; Pooja Khatri; John Castaldo; James Frey; James Gebel; Scott Kasner; Chelsea Kidwell; Thomas Kwiatkowski; Richard Libman; Richard Mackenzie; Phillip Scott; Sidney Starkman; R Jason Thurman Journal: Stroke Date: 2008-09-04 Impact factor: 7.914
Authors: Yingfang Tian; Boryana Stamova; Glen C Jickling; Dazhi Liu; Bradley P Ander; Cheryl Bushnell; Xinhua Zhan; Ryan R Davis; Piero Verro; William C Pevec; Nasim Hedayati; David L Dawson; Jane Khoury; Edward C Jauch; Arthur Pancioli; Joseph P Broderick; Frank R Sharp Journal: J Cereb Blood Flow Metab Date: 2011-12-14 Impact factor: 6.200
Authors: Hansel M Greiner; Paul S Horn; Katherine Holland; James Collins; Andrew D Hershey; Tracy A Glauser Journal: Epilepsia Date: 2012-11-21 Impact factor: 5.864